Contemporary anesthesia management for liver transplantation: A comparison of american and european methods

Middle East Journal of Anesthesiology

Volumn 21, Issue 2, 2011, Pages 251-260

  Bezinover, Dmitri ^a   Kadry, Zakiyah ^a   Janicki, Piotr ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; PROTHROMBIN COMPLEX CONCENTRATES;

ANESTHESIA; COMPARATIVE STUDY; ECONOMICS; EUROPE; HUMAN; LIVER TRANSPLANTATION; METHODOLOGY; MORTALITY; POSTOPERATIVE CARE; REVIEW; THROMBOELASTOGRAPHY; UNITED STATES;

ANESTHESIA; BLOOD COAGULATION FACTORS; EUROPE; HUMANS; LIVER TRANSPLANTATION; POSTOPERATIVE CARE; THROMBELASTOGRAPHY; UNITED STATES;

EID: 84857264117     PISSN: 05440440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. SPICAK J, VITKO S, RYSKA M, ET AL: Liver transplantation in Eastern Europe. Liver Transpl; 2000, 6:665-9.
2. VAN DER HILST CS, IJTSMA AJC, SLOOFF MJH, TENVERGERT ED: Cost of liver transplantation. Med Care Res; 2009, 66:3-22.
3. O'GRADY JG: Clinical economics review. Liver transplantation. Aliment Pharmacol Ther; 1997, 11:445-51.
4. JANICKI PK: Liver transplantation: anesthesia, perioperative management, and postoperative intensive care. In: Blumgart LH, editor. Surgery of the liver, biliary tract, and pancreas. 4th ed. Philadelphia: Saunders Elsevier 2007, 1703-16.
5. PRESTON FE, LAIDLAW ST, SAMPSON B, KITCHEN S: Rapid reversal of oral anticoagulation with warfarin by a ptothrombin complex concentrates (Beriplex): efficacy and safety in 42 patients. Br J Haematol; 2002, 116:619-24.
6. EVANS G, LUDDINGSTON R, BAGLIN T: Beriplex P/N reverses severe warfarin-induced overanticoagulation immediately and completely in patients presenting with major bleeding. Br J Haematol; 2001, 115:998-1001.
7. KOHLER M: Thrombogenicity of ptothrombin complex concentrates. Thromb Res; 1999, 95:13-7.
8. MOLENAAR IQ, WARNAAR N, GROEN H, TENVERGERT EM, SLOOFF MJH, PORTEA RJ: Efficacy and safety of antifibrinolytic drugs in liver transplantation. A systematic review and meta-analysis. Amer J Transp; 2006, 7:185-194.
9. HARLERT H: Blutgerinnungsstudien mit der thromboelastography, einem neuen untersuchungsverfahren. Klin Wochenscgr; 1948, 26:577-83.
10. WENKER OC, WOJCIECHOWSKI Z, SHEINBAUM R, ZISMAN E: Thromboelastography. Internet J Anesthesiology; 2000, vol. 1, number 3. Available form: URL: http://www.ispub.com/journal/the_internet_journal_of_anesthesiology/volume_1_number_3_1/article/thrombelastography.html
11. GERUTTI E, STRATTA C, ROMANGNOLI R, ET AL: Thromboelastogram monitoring in the preoperative period of hepatectomy for adult living liver donation. Liver Transpl; 2004, 10:289-94.
12. ICKX BE, VAN DER LINDEN FJ, MELOT C, ET AL: Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the liver transplantation. Transf; 2006, 46:596-605.
13. PERNER F, BORKA P, TÖRÖK É, DABÓCZI A, TORONYI É: Perspectives of donation and transplantation in Central Eastern Europe. Nefrologia; 1996, vol. XVI, Supl. 2:8-13.
14. GORDON RD, BISMUTH H: Hepatic transplantation in Europe: first report of the European Liver Transplant Registry. Lancet; 1987, 2:674-676.
15. ADAM R, LUCIDI V, KARAM V: Liver transplantation in Europe: is there a room for improvement? J Hepatol; 2005, 42(1):33-40.
16. BIRD SM, CALNE RY, SHARPLES LD: Analyse transplant outcomes in distinct epochs of follow-up. Lancet; 2006, 367(9525):1816; author reply 1816-7.
17. MANNUCCI PM: Haemostatic drags. N Engl J Med; 1998, 339:245-53.
18. SA HARDING, SV MALLETT, TD PEACHEY AND DJ COX: Use of heparinase modified thrombelastography in liver transplantation. BJA; 1997, 78:175-179.
19. SORENSEN ER, LORME TB, HEATH D: Thromboelastography: a means to transfusion reduction. Nurs Manage; 2005, 36:27-34.
20. MANNUCCI PM, LEVI M: Prevention and treatment of major blood loss. N Engl J Med; 2007, 356:2301-11.
21. MANGAN DT, TUDOR IC, DIETZEL C: The risk associated with aprotinin in cardiac surgery. N Engl J Med; 2006, 354:353-65.
22. FERGUSSON DA, HÉBERT PC, MAZER CD, FREMES S, MACADAMS C, MURKIN JM, TEOH K, ET AL: Comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med; 2008, 358:2319-31.
23. LENTSCHENER C, ROCHE K, OZIER Y: A review of aprotinin in orthotopic liver transplantation: can its harmful effects offset its beneficial effects? Anesth Analg; 2005, 100:1248-55.
24. BROELSCH CE, TESTA G, ALEXANDROU MALAGÓ M: Living related liver transplantation: medical and social aspects of a controversial therapy. BNJ; 2002, 50:143-145.
25. TOLOU GHAMARI Z, PALIZBAN AA: The History Of Liver And Renal Transplantation. The Internet Journal of Pharmacology 2003, vol. 2, no. 1. Available form: URL:http://www.ispub.com/journal/the_internet_journal_of_pharmacology/volume_2_number_1_50/article/the_history_of_liver_and_renal_transplantation_1-2.html
26. STARZL T: Liver transplantation. Gastroen; 1997, 112(1):288-291.
27. TANAKA K, OGURA Y, KIUCHI T, INOMATA Y, UEMOTO S, FURIKAWA H: Living donor liver transplantation: Eastern experience. HPB; 2004, 6:84-94.
28. DETRY O, ROOVER AD, DELWAIDE J, ET AL: Liver transplantation in Jehovah's Witness. Transpl Int; 2005, 18:929-36.
29. PHILLIPS SD, DESHPANDE R, MUIESAN P, BOWLES MJ, RELA M, HEATON ND: A prospective study investigating the cost effectiveness of Intraoperative blood salvage during liver transplantation. Transpl; 2006, 81:536-40.
30. STRONG RW: Liver transplantation: Current status and future prospects. J R Coll Surg Edinb; 2001, 46:1-8.
31. KEEFFE EB: Liver transplantation: Current status and novel approaches to replacement. Gastroent; 2001, 120:749-762
32. FINDLAY JY, JANKOWSKI CJ, VASDEV: Fast Track Anesthesia for Liver Transplantation Reduces Postoperative Ventilation Time but Not Intensive Care Unit Stay. Liver Transpl; 2002, 8:670-675.
33. MANDELL MS, LEZOTTE D, KAM I, ZAMUDIO S: Reduced use of intensive care after liver transplantation: influence of early extubation. Liver Transpl; 2002, 8:676-681.